The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
Welcome,         Profile    Billing    Logout  
 2 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tanaka, Yoshiya
APLCLLDAS, NCT03138941: Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Recruiting
N/A
5000
Japan, RoW
Monash University, Flinders Medical Centre, Adelaide, AUSTRALIA, St. Vincent's Hospital, Melbourne, AUSTRALIA, Royal Adelaide Hospital, Adelaide, AUSTRALIA, University of New South Wales, Sydney, AUSTRALIA, People's Hospital, Peking University Health Science Center, Beijing, CHINA, Peking University First Hospital, Beijing, CHINA, The University of Hong Kong, HONG KONG, University of Padjadjaran, Bandung, INDONESIA, Tokyo Women's Medical University, JAPAN, University of Occupational and Environmental Health, JAPAN, Keio University, JAPAN, Hanyang University Hospital for Rheumatic Diseases, REPUBLIC OF KOREA, University of Santo Tomas Hospital, Philippines, National University Hospital, Singapore, Tan Tock Seng Hospital, Chang Gung Memorial Hospital, Taichung Veterans General Hospital, Chiang Mai University Hospital, THAILAND, Middlemore Hospital, New Zealand, North Shore Hospital, Auckland, NEW ZEALAND, Auckland District Health Board, Auckland, NEW ZEALAND, Teaching Hospital Kandy, SRI LANKA, University of the Philippines, Philippines
Systemic Lupus Erythematosus
12/27
12/32
Zhang, Zhuoli
NCT06145893: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

Recruiting
3
162
RoW
Hemay005, Mufemilast, Phosphodiesterase 4 (PDE4) inhibitors, Placebo
Ganzhou Hemay Pharmaceutical Co., Ltd
Behçet's Disease
11/24
03/25
NCT04957550: To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Enrolling by invitation
3
444
RoW
SHR0302 tablets、Placebo, Placebo
Jiangsu HengRui Medicine Co., Ltd.
Psoriatic Arthritis
11/24
11/24
SMART, NCT06722586: Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Recruiting
3
84
RoW
Sirolimus, Rapamycin, mTOR inhibitor, Placebo
Peking University First Hospital, North China Pharmaceutical Co.,Ltd
Antiphospholipid (aPL)-positive, Thrombocytopaenia
12/27
12/27
APLCLLDAS, NCT03138941: Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Recruiting
N/A
5000
Japan, RoW
Monash University, Flinders Medical Centre, Adelaide, AUSTRALIA, St. Vincent's Hospital, Melbourne, AUSTRALIA, Royal Adelaide Hospital, Adelaide, AUSTRALIA, University of New South Wales, Sydney, AUSTRALIA, People's Hospital, Peking University Health Science Center, Beijing, CHINA, Peking University First Hospital, Beijing, CHINA, The University of Hong Kong, HONG KONG, University of Padjadjaran, Bandung, INDONESIA, Tokyo Women's Medical University, JAPAN, University of Occupational and Environmental Health, JAPAN, Keio University, JAPAN, Hanyang University Hospital for Rheumatic Diseases, REPUBLIC OF KOREA, University of Santo Tomas Hospital, Philippines, National University Hospital, Singapore, Tan Tock Seng Hospital, Chang Gung Memorial Hospital, Taichung Veterans General Hospital, Chiang Mai University Hospital, THAILAND, Middlemore Hospital, New Zealand, North Shore Hospital, Auckland, NEW ZEALAND, Auckland District Health Board, Auckland, NEW ZEALAND, Teaching Hospital Kandy, SRI LANKA, University of the Philippines, Philippines
Systemic Lupus Erythematosus
12/27
12/32
Miyasaki, Yusuke
APLCLLDAS, NCT03138941: Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Recruiting
N/A
5000
Japan, RoW
Monash University, Flinders Medical Centre, Adelaide, AUSTRALIA, St. Vincent's Hospital, Melbourne, AUSTRALIA, Royal Adelaide Hospital, Adelaide, AUSTRALIA, University of New South Wales, Sydney, AUSTRALIA, People's Hospital, Peking University Health Science Center, Beijing, CHINA, Peking University First Hospital, Beijing, CHINA, The University of Hong Kong, HONG KONG, University of Padjadjaran, Bandung, INDONESIA, Tokyo Women's Medical University, JAPAN, University of Occupational and Environmental Health, JAPAN, Keio University, JAPAN, Hanyang University Hospital for Rheumatic Diseases, REPUBLIC OF KOREA, University of Santo Tomas Hospital, Philippines, National University Hospital, Singapore, Tan Tock Seng Hospital, Chang Gung Memorial Hospital, Taichung Veterans General Hospital, Chiang Mai University Hospital, THAILAND, Middlemore Hospital, New Zealand, North Shore Hospital, Auckland, NEW ZEALAND, Auckland District Health Board, Auckland, NEW ZEALAND, Teaching Hospital Kandy, SRI LANKA, University of the Philippines, Philippines
Systemic Lupus Erythematosus
12/27
12/32

Download Options